HDS CDTR Health Disparities Core

HDS CDTR 健康差异核心

• 批准号: 9186356
• 负责人: Andrew John Karter
• 金额: $ 7.1万
• 依托单位: KAISER FOUNDATION RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2021-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9186356
• 关键词: Address; Affect; American; Area; California; Caring; Centers for Disease Control and Prevention (U.S.); Chronic Disease; Clinical; Clinical Trials; Collaborations; Consult; Development; Diabetes Mellitus; Diabetes prevention; Disadvantaged; Effectiveness; Ensure; Epidemiologic Studies; Ethnic group; Evaluation; Financial Support; Fostering; Foundations; Funding; Goals; Health; Health system; Healthcare; Healthcare Systems; Institutes; Integrated Delivery Systems; Intervention; Knowledge; Methods; Minority; Mission; Modeling; Monitor; Morbidity - disease rate; Morehouse School of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases; Non-Insulin-Dependent Diabetes Mellitus; Outcome; Paper; Patients; Populations at Risk; Prevalence; Prevention; Provider; Public Health; Publications; Publishing; Quality of Care; Recording of previous events; Research; Research Activity; Research Infrastructure; Research Personnel; Research Project Grants; Research Support; Resources; Risk Factors; San Francisco; Site; Structure; Subgroup; Support System; System; Testing; Translating; Translational Research; Translations; Underrepresented Minority; Underserved Population; United States; Universities; Vulnerable Populations; collaborative environment; cost; diabetes prevention program; diabetes risk; education research; effective intervention; ethnic minority population; evidence base; health care delivery; health care disparity; health difference; health disparity; health information technology; health literacy; high risk; innovation; low socioeconomic status; meetings; minority investigator; mortality; novel; obesity prevention; operation; prevent; programs; ranpirnase; response; safety net; social; social group; symposium; systems research

Diabetes mellitus is a significant health burden in the United States, affecting more than 20,000,000 people and costing more than $100 billion annually. The prevalence of Type 2 diabetes (T2DM) is growing rapidly; the CDC estimates that up to 1/3 of Americans will have diabetes by the year 2050. The burden of T2DM is particularly great among ethnic minority populations and those of lower socioeconomic status. The evidence base for the prevention and care of T2DM is one of the most well-established of any chronic illness: clinical trials have shown the efficacy of cardiometabolic therapies in preventing mortality and morbidity in diabetes, and programs such as the Diabetes Prevention Program (DPP) have demonstrated that diabetes can be prevented in high-risk patients. However, the overall quality of care for diabetes remains sub-optimal, significant disparities in diabetes care and prevention persist, and there are very few effective populationbased efforts to systematically reduce prevent diabetes and reduce diabetes risk. Programs that can effectively translate high-quality, evidence-based diabetes prevention and treatment into widespread practice are desperately needed. In response to this need, diabetes researchers at the Kaiser Permanente Northern California Division of Research, HealthPartners Institute for Education and Research, Harvard Pilgrim Health Care Institute, and the University of California San Francisco (UCSF) created the Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) in 2011 (P30 DK092924). This CDTR fosters and supports translational research in diabetes within health care delivery systems affiliated with the Health Care Systems Research Network (formerly known as the HMO Research Network) and with UCSF. The HDS- CDTR brings together a multi-disciplinary network of well-established investigators with a strong history of receiving federal and foundation funding in diabetes translational research. The HDS-CDTR is structured around three Translational Research Cores in the areas of health care disparities; diabetes and obesity prevention; and health information technology. HDS-CDTR investigators have strong relationships with delivery systems, ranging from large integrated delivery systems to networks of safety net providers that serve as key partners for translating effective interventions into real-world clinical settings. Our CDTR will continue to be a strong resource to underresourced delivery systems across the U.S. through its Resource Core, which will continue and expand our support of these systems in their efforts to provide high quality diabetes prevention and care. In addition, the HDS-CDTR is expanding its mission to address disparities through the creation of a new Core for Underserved Populations that will develop a strong partnership with junior and senior Underrepresented Minority (URM) investigators at the Morehouse School of Medicine.

糖尿病是美国的重大健康负担，影响超过20,000,000 人们每年耗资超过1000亿美元。 2型糖尿病（T2DM）的患病率正在增长 迅速疾病预防控制中心估计，到2050年，多达1/3的美国人将患有糖尿病。 T2DM在少数民族和社会经济地位较低的人群中尤其重要。这 预防和护理T2DM的证据基础是任何慢性疾病中最有公认的： 临床试验表明，心脏代谢疗法在预防死亡率和发病率方面的功效 糖尿病和糖尿病预防计划（DPP）等计划表明糖尿病可以 高危患者可以预防。但是，糖尿病的总体护理质量仍然是最佳的， 糖尿病护理和预防的显着差异持续存在，有效的人群很少 努力系统地减少糖尿病并降低糖尿病风险。可以有效的程序 将高质量，基于证据的糖尿病预防和治疗转化为广泛的实践是 迫切需要。 为了应对这一需求，Kaiser Permanente North California司的糖尿病研究人员 研究，HealthPartners教育与研究所，哈佛大学朝圣者卫生保健研究所和 加利福尼亚大学旧金山大学（UCSF）创建了糖尿病的健康输送系统中心 2011年转化研究（HDS-CDTR）（P30 DK092924）。此CDTR促进并支持翻译 医疗保健系统研究隶属于医疗保健提供系统中糖尿病的研究 网络（以前称为HMO研究网络）和UCSF。 HDS- CDTR汇集了 良好的调查员的多学科网络，该研究人员有悠久的历史，即接受联邦和 糖尿病转化研究中的基金会资金。 HDS-CDTR的结构大约是三个翻译 医疗保健差异领域的研究核心；糖尿病和肥胖预防；和健康信息 技术。 HDS-CDTR调查人员与交付系统有牢固的关系，从大型 将交付系统集成到安全网络提供商网络，这些提供商是翻译的关键合作伙伴 有效干预现实世界临床环境。我们的CDTR将继续成为资源不足的强大资源 通过其资源核心，美国各地的交付系统将继续并扩展我们 支持这些系统为提供高质量糖尿病预防和护理的努力。另外， HDS-CDTR正在扩大通过创建新的核心来解决差异的使命 人口将与初级和高级代表性不足的少数民族（URM）建立牢固的伙伴关系 莫尔豪斯医学院的调查人员。